window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 6, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Real World Evidence

  • Biotech & Pharma Business

    Prescient integrates Uptake and Dolon to create 550-strong pharma consultancy

    Prescient Healthcare Group has completed the integration of Uptake and [...]

    August 14, 2026
  • Digital & Data,Drug Discovery & Development,Research & Development,Therapeutic Areas

    Nucs AI taps Segmed’s 150 million imaging studies to strengthen oncology AI

    Nucs AI has partnered with healthcare data specialist Segmed to [...]

    July 15, 2026
  • Digital & Data,Medical devices,Research & Development

    Seegene launches global million-patient study of syndromic PCR testing

    Seegene has launched a global clinical study involving one million [...]

    July 9, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    AstraZeneca highlights long-term remission and steroid-sparing data for Saphnelo at EULAR 2026

    AstraZeneca is presenting a broad package of new clinical and [...]

    June 9, 2026
  • Clinical & Regulatory,Digital & Data,Therapeutic Areas

    Grow Therapy study finds most patients report meaningful improvement in depression and anxiety symptoms

    Grow Therapy has published its first peer-reviewed outcomes study, reporting [...]

    May 14, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    Japan pushes AI clinical trials agenda as global pharma leaders gather in Tokyo

    Japan’s push to modernise clinical research through artificial intelligence and [...]

    May 7, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    MaaT Pharma publishes real-world CHRONOS data in third-line acute GvHD

    MaaT Pharma has published retrospective real-world data from its CHRONOS [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Opinion & Events

    Phesi data highlights 6.7% of global clinical trials affected by Middle East disruption

    New analysis from Phesi suggests 6.7% of globally recruiting clinical [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Therapeutic Areas

    Quest Diagnostics launches flow cytometry MRD blood test for myeloma to support ultrasensitive monitoring

    Quest Diagnostics has introduced a new blood-based test for measurable [...]

    May 5, 2026
  • Clinical & Regulatory,Therapeutic Areas

    Rapid sepsis test linked to lower mortality and shorter hospital stays in academic centre study

    A rapid sepsis test used in the emergency department at [...]

    May 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Piramal Pharma reports 22.6% emissions reduction and zero OAI observations in sustainability report
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Research & Development
  • FDA approves ViiV’s Tivicay PD for young children with HIV
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Centrix and University of Sussex launch £375,000 data science project for drug development
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development, Manufacturing & Supply Chain, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top